These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2676965)

  • 1. Treatment of ADDH in mentally retarded children: a preliminary study.
    Payton JB; Burkhart JE; Hersen M; Helsel WJ
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):761-7. PubMed ID: 2676965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
    Varley CK; Trupin EW
    Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and noneffects of methylphenidate in children with mental retardation and ADHD.
    Handen BL; Breaux AM; Janosky J; McAuliffe S; Feldman H; Gosling A
    J Am Acad Child Adolesc Psychiatry; 1992 May; 31(3):455-61. PubMed ID: 1592777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
    Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 11. Testing the ability of children with attention deficit hyperactivity disorder to accurately report the effects of medication on their behavior.
    Ardoin SP; Martens BK
    J Appl Behav Anal; 2000; 33(4):593-610. PubMed ID: 11214033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate and cognitive therapy in children with attention deficit disorder: a double-blind trial.
    Brown RT; Wynne ME; Borden KA; Clingerman SR; Geniesse R; Spunt AL
    J Dev Behav Pediatr; 1986 Jun; 7(3):163-74. PubMed ID: 3522630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Task demands interact with the single and combined effects of medication and contingencies on children with ADHD.
    Tamm L; Carlson CL
    J Atten Disord; 2007 May; 10(4):372-80. PubMed ID: 17449836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant drug therapy in hyperactive children: research and clinical implications.
    Wolraich ML
    Pediatrics; 1977 Oct; 60(4):512-8. PubMed ID: 333368
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.
    Gulley V; Northup J; Hupp S; Spera S; LeVelle J; Ridgway A
    J Appl Behav Anal; 2003; 36(3):375-8. PubMed ID: 14596580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 19. Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects.
    Aman MG; Kern RA; Osborne P; Tumuluru R; Rojahn J; del Medico V
    Am J Ment Retard; 1997 Mar; 101(5):521-34. PubMed ID: 9083608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.